Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition

International Journal of Oncology

Volumn 29, Issue 6, 2006, Pages 1501-1508

  Matsumoto, Kazuya ^a   Okano, Jun Ichi ^a   Nagahara, Takakazu ^a   Murawaki, Yoshikazu ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Apoptosis; Extracellular signal regulated kinase; Liver cancer; Vitamin K2

Indexed keywords

1,3 BUTADIENE DERIVATIVE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; FARNOQUINONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRILE; PROTEIN KINASE INHIBITOR;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL GROWTH; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APOPTOSIS; BUTADIENES; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DRUG SYNERGISM; ENZYME ACTIVATION; HUMANS; LIVER NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRILES; PROTEIN KINASE INHIBITORS; VITAMIN K 2;

EID: 39049194858     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.6.1501     Document Type: Article

References (18)

1. Tabb MM, Sun A, Zhou C, Grun F, Errandi J, Romero K, Pham H, Inoue S, Mallick S, Lin M, Forman BM and Blumberg B: Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem 278: 43919-43927, 2003.
2. Habu D, Shiomi S, Tamori A, Takeda T, Tanaka T, Kubo S and Nishiguchi S: Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver. JAMA 292: 358-361, 2004. (Pubitemid 38944260)
3. Mizuta T, Ozaki I, Eguchi Y, Yasutake T, Kawazoe S, Fujimoto K and Yamamoto K: The effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment: a pilot study. Cancer 106: 867-872, 2006. (Pubitemid 43238454)
4. Yokoyama T, Miyazawa K, Yoshida T and Ohyashiki K: Combination of vitamin K2 plus imatinib mesylate enhances induction of apoptosis in small cell lung cancer cell lines. Int J Oncol 26: 33-40, 2005.
5. Miyazawa K, Yaguchi M, Funato K, Gotoh A, Kawanishi Y, Nishizawa Y, Yuo A and Ohyashiki K: Apoptosis/ differentiation-inducing effects of vitamin K2 on HL-60 cells: dichotomous nature of vitamin K2 in leukemia cells. Leukemia 15: 1111-1117, 2001. (Pubitemid 32717282)
6. Otsuka M, Kato N, Shao RX, Hoshida Y, Ijichi H, Koike Y, Taniguchi H, Moriyama M, Shiratori Y, Kawabe T and Omata M: Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation. Hepatology 40: 243-251, 2004. (Pubitemid 38868943)
7. Wang Z, Wang M, Finn F and Carr BI: The growth inhibitory effects of vitamins K and their actions on gene expression. Hepatology 22: 876-882, 1995.
8. MacKeigan JP, Collins TS and Ting JP: MEK inhibition enhances paclitaxel-induced tumor apoptosis. J Biol Chem 275: 38953-38956, 2000.
9. Okano J, Matsumoto K, Nagahara T and Murawaki Y: Gefitinib and the modulation of the signaling pathways downstream of epidermal growth factor receptor in human liver cancer cells. J Gastroenterol 41: 166-176, 2006.
10. Weitz IC and Liebman HA: Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review. Hepatology 18: 990-997, 1993.
11. Huisse MG, Leclercq M, Belghiti J, Flejou JF, Suttie JW, Bezeaud A, Stafford DW and Guillin MC: Mechanism of the abnormal vitamin K-dependent gamma-carboxylation process in human hepatocellular carcinomas. Cancer 74: 1533-1541, 1994. (Pubitemid 24302971)
12. Shino M, Yamashiro T, Yamada K, Mori Y, Sato T, Kawabe K and Okada K: Determination of menaquinone-4 in plasma after administration of menaquinone-4 dosage forms in healthy human subjects. Yakugaku Zasshi 102: 651-658, 1982. (Pubitemid 12001838)
13. Wada T and Penninger JM: Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23: 2838-2849, 2004.
14. Agazie Y, Ischenko I and Hayman M: Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogene. Oncogene 21: 697-707, 2002.
15. Tsukada Y, Miyazawa K and Kitamura N: High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2. J Biol Chem 276: 40968-40976, 2001.
16. Adachi T, Kar S, Wang M and Carr BI: Transient and sustained ERK phosphorylation and nuclear translocation in growth control. J Cell Physiol 192: 151-159, 2002. (Pubitemid 34747783)
17. Mareninova OA, Sung KF, Hong P, Lugea A, Pandol SJ, Gukovsky I and Gukovskaya AS: Cell death in pancreatitis: caspases protect from necrotizing pancreatitis. J Biol Chem 281: 3370-3381, 2006. (Pubitemid 43845951)
18. Yoshida T, Miyazawa K, Kasuga I, Yokoyama T, Minemura K, Ustumi K, Aoshima M and Ohyashiki K: Apoptosis induction of vitamin K2 in lung carcinoma cell lines: the possibility of vitamin K2 therapy for lung cancer. Int J Oncol 23: 627-632, 2003.